No involvement of the adenosine A2A receptor in tardive dyskinesia in Russian psychiatric inpatients from Siberia

Hum Psychopharmacol. 2012 May;27(3):334-7. doi: 10.1002/hup.2226.

Abstract

Background: The adenosine A2A receptor forms a heteromeric complex with the striatal dopamine D2 receptor. We examined whether a specific polymorphism in adenosine A2A receptor (2592 C/Tins) is associated with tardive dyskinesia.

Methods: Tardive dyskinesia was assessed cross-sectionally in 146 Caucasian psychiatric inpatients from Siberia.

Results: Between-group comparisons of genotypic or allelic frequencies showed no statistically significant difference. Logistic regression analysis with the occurrence of tardive dyskinesia as dependent variable showed no significant association with age, duration of illness, gender, and genotype.

Conclusion: The interaction between the A2A and D2 receptors seems not involved in the development of tardive dyskinesia.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Antipsychotic Agents / adverse effects*
  • Cross-Sectional Studies
  • Dyskinesia, Drug-Induced / etiology*
  • Dyskinesia, Drug-Induced / genetics*
  • Female
  • Gene Frequency
  • Genetic Association Studies
  • Genotype
  • Hospitalization / statistics & numerical data
  • Humans
  • Inpatients
  • Logistic Models
  • Male
  • Middle Aged
  • Receptor, Adenosine A2A / genetics*
  • Receptors, Dopamine D2 / genetics
  • Schizophrenia / drug therapy
  • Siberia / epidemiology
  • Siberia / ethnology

Substances

  • Antipsychotic Agents
  • Receptor, Adenosine A2A
  • Receptors, Dopamine D2